Key Specifications Table
|Species Reactivity||Key Applications||Host||Format||Antibody Type|
|M, R, Fe||ICC, IHC, IP, WB||M||Purified||Monoclonal Antibody|
|Presentation||Purified immunoglobulin. Liquid.|
|Safety Information according to GHS|
|Material Size||100 µg|
Anti-Notch 1 Antibody, clone mN1A SDS
|Anti-Notch1, clone mN1A Monoclonal Antibody||Q2925513|
|MOUSE ANTI-MOUSE NOTCH1 MONOCLONAL ANTIBODY - 2378672||2378672|
|MOUSE ANTI-MOUSE NOTCH1 - 2495871||2495871|
|MOUSE ANTI-MOUSE NOTCH1 - 3837165||3837165|
|MOUSE ANTI-MOUSE NOTCH1 -2554880||2554880|
|MOUSE ANTI-MOUSE NOTCH1 -2594368||2594368|
|MOUSE ANTI-MOUSE NOTCH1 -2619292||2619292|
|MOUSE ANTI-MOUSE NOTCH1 -2631127||2631127|
|MOUSE ANTI-MOUSE NOTCH1 -2793624||2793624|
|MOUSE ANTI-MOUSE NOTCH1 MONOCLONAL ANTIBODY||3158915|
|Reference overview||Pub Med ID|
|MDM2 protein-mediated ubiquitination of numb protein: identification of a second physiological substrate of MDM2 that employs a dual-site docking mechanism.|
Sczaniecka, M; Gladstone, K; Pettersson, S; McLaren, L; Huart, AS; Wallace, M
The Journal of biological chemistry 287 14052-68 2012
The E3 ubiquitin ligase, MDM2, uses a dual-site mechanism to ubiquitinate and degrade the tumor suppressor protein p53, involving interactions with the N-terminal hydrophobic pocket and the acidic domain of MDM2. The results presented here demonstrate that MDM2 also uses this same dual-site mechanism to bind to the cell fate determinant NUMB with both the N-terminal hydrophobic pocket and the acidic domain of MDM2 also involved in forming the interaction with NUMB. Furthermore, the acidic domain interactions are crucial for MDM2-mediated ubiquitination of NUMB. Contrary to p53, where two separate domains form the interface with MDM2, only one region within the phosphotyrosine binding domain of NUMB (amino acids 113-148) mediates binding to both these regions of MDM2. By binding to both domains on MDM2, NUMB disrupts the MDM2-p53 complex and MDM2-catalyzed ubiquitination of p53. Therefore, we have identified the mechanism NUMB uses to regulate the steady-state levels of the p53 in cells. By targeting the acidic domain of MDM2 using acid domain-binding ligands we can overcome MDM2-mediated ubiquitination and degradation of NUMB impacting on the stabilization of p53 in cells. Furthermore, delivery of MDM2 acid domain-binding ligands to cancer cells promotes p53-dependent growth arrest and the induction of apoptosis. This highlights the dual-site mechanism of MDM2 on another physiological substrate and identifies the acid domain as well as N terminus as a potential target for small molecules that inhibit MDM2.
|Notch1 in primary effusion lymphoma: a clinicopathological study.|
Wang, Huan-You, et al.
Mod. Pathol., 23: 773-80 (2010) 2010
Primary effusion lymphoma is a human herpes virus 8 (HHV-8)-associated large cell lymphoma of body cavities. Detailed large-scale clinicopathological studies are rarely reported, and the underlying mechanism of lymphomagenesis remains elusive. In the present report, we studied the clinicodemographic, immunophenotypic, and cytomorphological features on a cohort of 12 cases of primary effusion lymphoma. In contrast to HHV-8, which was positive in all nine cases tested (100%), HIV was found in 75% (9/12) of cases, whereas the three HIV-negative cases were either in elderly patients (one with hepatitis C virus infection and one with asbestoses exposure) or in a heart transplantation recipient. By flow cytometry, the antigens expressed in descending order were CD38, CD71, HLA-DR, CD30, and CD45RO. B-cell markers were largely negative. Cytomorphologically, all cases showed atypical to anaplastic morphology. Notch1, a member of transmembrane signal transduction family, was found in six of seven HHV-8-positive cases (86%). In agreement with in vitro studies using human primary effusion lymphoma cell lines, we have found that Notch1 was expressed in the majority of HHV-8-positive primary effusion lymphoma cases, corroborating the notion that Notch1 may have an important role in HHV-8-mediated lymphomagenesis of primary effusion lymphoma.
|Activation of the Notch pathway in Down syndrome: cross-talk of Notch and APP.|
Fischer, DF; van Dijk, R; Sluijs, JA; Nair, SM; Racchi, M; Levelt, CN; van Leeuwen, FW; Hol, EM
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 19 1451-8 2005
Down syndrome (DS) patients suffer from mental retardation, but also display enhanced beta-APP production and develop cortical amyloid plaques at an early age. As beta-APP and Notch are both processed by gamma-secretase, we analyzed expression of the Notch signaling pathway in the adult DS brain and in a model system for DS, human trisomy 21 fibroblasts by quantitative PCR. In adult DS cortex we found that Notch1, Dll1 and Hes1 expression is up-regulated. Moreover, DS fibroblasts and Alzheimer disease cortex also show overexpression of Notch1 and Dll1, indicating that enhanced beta-APP processing found in both DS and AD could be instrumental in these changes. Using pull-down studies we could demonstrate interaction of APP with Notch1, suggesting that these transmembrane proteins form heterodimers, but independent of gamma-secretase. We could demonstrate binding of the intracellular domain of Notch1 to the APP adaptor protein Fe65. Furthermore, activated Notch1 can trans-activate an APP target gene, Kai1, and vice versa, activated APP can trans-activate the classical Notch target gene Hes1. These data suggest that Notch expression is activated in Down syndrome, possibly through cross-talk with APP signaling. This interaction might affect brain development, since the Notch pathway plays a pivotal role in neuron-glia differentiation.
|Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1.|
Huppert, S S, et al.
Nature, 405: 966-70 (2000) 2000
|Inhibition of granulocytic differentiation by mNotch1.|
Milner, L A, et al.
Proc. Natl. Acad. Sci. U.S.A., 93: 13014-9 (1996) 1996
Effective hematopoiesis requires the commitment of pluripotent and multipotent stem cells to distinct differentiation pathways, proliferation and maturation of cells in the various lineages, and preservation of pluripotent progenitors to provide continuous renewal of mature blood cells. While the importance of positive and negative cytokines in regulating proliferation and maturation of hematopoietic cells has been well documented, the factors and molecular processes involved in lineage commitment and self-renewal of multipotent progenitors have not yet been defined. In other developmental systems, cellular interactions mediated by members of the Notch gene family have been shown to influence cell fate determination by multipotent progenitors. We previously described the expression of the human Notch1 homolog, TAN-1, in immature hematopoietic precursors. We now demonstrate that constitutive expression of the activated intracellular domain of mouse Notch1 in 32D myeloid progenitors inhibits granulocytic differentiation and permits expansion of undifferentiated cells, findings consistent with the known function of Notch in other systems.